Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database

**Background:** Current knowledge of the disease burden of primary Sjögren’s syndrome (pSS) is limited. **Objectives:** The primary objective of this study was to describe the demographic and clinical characteristics of patients with pSS. The secondary objective was to describe the treatment patter...

Full description

Saved in:
Bibliographic Details
Main Authors: Sue Perera, Liyuan Ma, Raj Punwaney, Sulabha Ramachandran
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2018-02-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/9807
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823860371113377792
author Sue Perera
Liyuan Ma
Raj Punwaney
Sulabha Ramachandran
author_facet Sue Perera
Liyuan Ma
Raj Punwaney
Sulabha Ramachandran
author_sort Sue Perera
collection DOAJ
description **Background:** Current knowledge of the disease burden of primary Sjögren’s syndrome (pSS) is limited. **Objectives:** The primary objective of this study was to describe the demographic and clinical characteristics of patients with pSS. The secondary objective was to describe the treatment patterns and healthcare resource utilization of patients with pSS. Furthermore, clinical characteristics of interest were described and the proportions of patients with glandular versus extra-glandular disease were reported. **Methods:** This was a retrospective cohort study (HO-15-16077) conducted in the US Truven MarketScan Commercial database. We report descriptive data from employees and their families, as covered by employer-sponsored medical insurance. The primary cohort comprised patients with pSS (with ≥1 diagnosis of sicca syndrome prior to January 1, 2013), with continuous enrollment for ≥24 months (January 1, 2012–December 31, 2013). Patients with conditions mimicking sicca symptoms not due to SS were excluded, as were those with connective tissue disease that may have suggested secondary SS. To compare the healthcare burden of patients with and without sicca symptoms, a 1:1 matched comparator population comprising subjects without a previous diagnosis of sicca syndrome (sicca-free) was also identified. **Results:** There were 12 717 eligible patients in the primary cohort. The majority (86%) was female and the mean age was 51 years. Overall, 60.7% of patients had claims associated with pSS extra glandular disease manifestations. These patients experienced a higher disease burden, and more commonly reported pain, fatigue or insomnia and any combination of pain, fatigue or insomnia (41.3%) compared with patients with glandular disease only (12.4%). Patients in the primary cohort incurred greater annual healthcare service costs (1.6 times greater, all causes) and healthcare resource utilization compared with the sicca-free comparator cohort. Patients with extra glandular disease also incurred greater average annual costs (2.9 times) contributing to ≥2 times/year more resource use for outpatient services than patients with glandular disease only. **Conclusion:** Patients with pSS experience a high disease burden despite treatment. This study provides novel insights in to the extent of the burden on healthcare resources among patients with pSS, in particular for patients with extra-glandular disease manifestations, when compared with sicca-free subjects.
format Article
id doaj-art-bc3b9281b7864bc0be5e551cf4a4d71c
institution Kabale University
issn 2327-2236
language English
publishDate 2018-02-01
publisher Columbia Data Analytics, LLC
record_format Article
series Journal of Health Economics and Outcomes Research
spelling doaj-art-bc3b9281b7864bc0be5e551cf4a4d71c2025-02-10T16:12:35ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362018-02-0152Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims DatabaseSue PereraLiyuan MaRaj PunwaneySulabha Ramachandran**Background:** Current knowledge of the disease burden of primary Sjögren’s syndrome (pSS) is limited. **Objectives:** The primary objective of this study was to describe the demographic and clinical characteristics of patients with pSS. The secondary objective was to describe the treatment patterns and healthcare resource utilization of patients with pSS. Furthermore, clinical characteristics of interest were described and the proportions of patients with glandular versus extra-glandular disease were reported. **Methods:** This was a retrospective cohort study (HO-15-16077) conducted in the US Truven MarketScan Commercial database. We report descriptive data from employees and their families, as covered by employer-sponsored medical insurance. The primary cohort comprised patients with pSS (with ≥1 diagnosis of sicca syndrome prior to January 1, 2013), with continuous enrollment for ≥24 months (January 1, 2012–December 31, 2013). Patients with conditions mimicking sicca symptoms not due to SS were excluded, as were those with connective tissue disease that may have suggested secondary SS. To compare the healthcare burden of patients with and without sicca symptoms, a 1:1 matched comparator population comprising subjects without a previous diagnosis of sicca syndrome (sicca-free) was also identified. **Results:** There were 12 717 eligible patients in the primary cohort. The majority (86%) was female and the mean age was 51 years. Overall, 60.7% of patients had claims associated with pSS extra glandular disease manifestations. These patients experienced a higher disease burden, and more commonly reported pain, fatigue or insomnia and any combination of pain, fatigue or insomnia (41.3%) compared with patients with glandular disease only (12.4%). Patients in the primary cohort incurred greater annual healthcare service costs (1.6 times greater, all causes) and healthcare resource utilization compared with the sicca-free comparator cohort. Patients with extra glandular disease also incurred greater average annual costs (2.9 times) contributing to ≥2 times/year more resource use for outpatient services than patients with glandular disease only. **Conclusion:** Patients with pSS experience a high disease burden despite treatment. This study provides novel insights in to the extent of the burden on healthcare resources among patients with pSS, in particular for patients with extra-glandular disease manifestations, when compared with sicca-free subjects.https://doi.org/10.36469/9807
spellingShingle Sue Perera
Liyuan Ma
Raj Punwaney
Sulabha Ramachandran
Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
Journal of Health Economics and Outcomes Research
title Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
title_full Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
title_fullStr Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
title_full_unstemmed Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
title_short Clinical and Cost Burden of Primary Sjögren’s Syndrome: Descriptive Analysis Using a US Administrative Claims Database
title_sort clinical and cost burden of primary sjogren s syndrome descriptive analysis using a us administrative claims database
url https://doi.org/10.36469/9807
work_keys_str_mv AT sueperera clinicalandcostburdenofprimarysjogrenssyndromedescriptiveanalysisusingausadministrativeclaimsdatabase
AT liyuanma clinicalandcostburdenofprimarysjogrenssyndromedescriptiveanalysisusingausadministrativeclaimsdatabase
AT rajpunwaney clinicalandcostburdenofprimarysjogrenssyndromedescriptiveanalysisusingausadministrativeclaimsdatabase
AT sulabharamachandran clinicalandcostburdenofprimarysjogrenssyndromedescriptiveanalysisusingausadministrativeclaimsdatabase